Faculty Publications Home

Publications for Russell Caccavello russell.caccavello@tu.edu

College of Osteopathic Medicine (TUC)

  • Gugliucci, A, Kotani, K., & Caccavello, R. (2012). Circulating soluble receptor for advanced glycation end products is inversely correlated to oxidized low-density lipoproteins in healthy participants. Journal of the American Osteopathic Association, 112(8), 538.

  • Kotani, K., Caccavello, R., Mutou, T., Yamada, T., Taniguchi, N., & Gugliucci, A. (2012). Association between reactive oxygen metabolites and paraoxonase 1 activity during a physical activity increase intervention with older Japanese people. Australasian Journal on Ageing, 31(4), 222-226. doi:10.1111/j.1741-6612.2011.00569.x

    		•

  • Menini, T., Caccavello, R., Kimura, S., & Gugliucci, A. (2012). Circulating soluble receptors for advanced glycation end products increase after a cerebrovascular accident and may be a marker for cerebral inflammation: A follow-up pilot study. Journal of the American Osteopathic Association, 112(8), 540.

  • Takada, C., Caccavello, R., Kimura, S., & Gugliucci, A. (2012). Paraoxonase-1 and ischemia-modified albumin excursions after a cerebrovascular accident: A pilot study. Journal of the American Osteopathic Association, 112(8), 539.

  • Engdahl, C., Caccavello, R. , Kimura, S., & Gugliucci, A. (2011). Increase in paraonase I activity after hemodialysis is not caused by changes in high density liproprotein subclasses. Journal of the American Osteopathic Association, 111(8), 497.

  • Gugliucci, A., Kinugasa, E., Kotani, K., Caccavello, R., & Kimura, S. (2011). Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis. Clinical Chemistry and Laboratory Medicine, 49(1), 61-67. doi:10.1515/CCLM.2011.004

    		•

  • Gugliucci, A., Kotani, K., & Caccavello, R. (2011). Influence of ezetimbe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients. Journal of the American Osteopathic Association, 111(8), 494.

  • Gugliucci, A., Kotani, K., & Caccavello, R. (2011). Influence of physical activity intervention on circulating soluble receptor for advanced glycation end products in elderly subjects. Journal of the American Osteopathic Association, 111(8), 495.

  • Gugliucci, A, Kotani, K, Ishibashi, I, Caccavello, R, & Miyamoto, M. (2011). Influence of a short-term change in glucose and cholesterol concentrations on aspirin esterase activity in patients with type 2 diabetes mellitus [Supplemental material]. Diabetes, 60, A144. doi:10.2337/db11-478-715

    		•

  • Gugliucci, A., Menini, T., Kotani, K., & Caccavello, R. (2011). Serum paraoxonase esterase and lactonase activities correlate with intermediate size HDL particles. Journal of the American Osteopathic Association, 111(8), 495.

  • Kotani, K., Caccavello, R., Sakane, N., Miyamoto, M., & Gugliucci, A. (2011). Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients. Pharmacological Reports, 63(5), 1248-1251. doi:10.1016/S1734-1140(11)70646-6

    		•

  • Kotani, K., Caccavello, R., Sakane, N., Yamada, T., Taniguchi, N. & Gugliucci, A. (2011). Influence of physical activity intervention on circulating soluble receptor for advanced glycation end products in elderly subjects. Journal of Clinical Medicine Research, 3(5), 252-257.

  • Kotani, K., Kimura, S., Kinugasa, E., Ogata, H., Caccavello, R., & Gugliucci, A. (2011). Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease. Journal of Physiology and Biochemistry, 67(3), 437-441. This material can be found here.

  • Kotani, K., Kimura, S., Kinugasa, E., Ogata, H., Caccavello, R., Taniguchi, N., & Gugliucci, A. (2011). Correlation between ischaemia-modified albumin and intermediate-density lipoprotein in haemodialysis patients with end-stage renal disease. Journal of International Medical Research, 39(4), 1541-1545.

  • Gugliucci, A., Kotani, K., Kinugasa, E., Hermo, R., Caccavello, R., & Kimura, S. (2010). Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysis. Annals of Clinical Biochemistry, 47(6), 559-563. This material can be found here.

  • Kotani, K., Caccavello, R., Hermo, R., Yamada, T., Taniguchi, N., & Gugliucci, A. (2010). Serum cholesterol concentration associated with aspirin esterase activity in older people: Preliminary data. International Journal of Medical Studies, 7(1), 90-93. This material can be found here.

First Prev 1 2 Next Last